Q2 2022 Earnings Forecast for HCA Healthcare, Inc. (NYSE:HCA) Issued By SVB Leerink

HCA Healthcare, Inc. (NYSE:HCA – Get Rating) – Stock analysts at SVB Leerink dropped their Q2 2022 earnings per share estimates for shares of HCA Healthcare in a research report issued to clients and investors on Friday, July 15th. SVB Leerink analyst W. Mayo now anticipates that the company will earn $3.55 per share for the quarter, down from their prior estimate of $3.81. SVB Leerink currently has a “Outperform” rating and a $212.00 target price on the stock. The consensus estimate for HCA Healthcare’s current full-year earnings is $16.57 per share. SVB Leerink also issued estimates for HCA Healthcare’s Q4 2022 earnings at $5.05 EPS, Q1 2023 earnings at $4.05 EPS and Q3 2023 earnings at $3.93 EPS.

HCA Healthcare (NYSE:HCA – Get Rating) last issued its quarterly earnings results on Friday, April 22nd. The company reported $4.12 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.27 by ($0.15). The company had revenue of $14.95 billion during the quarter, compared to the consensus estimate of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The firm’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.14 earnings per share.

Other analysts have also issued research reports about the company. UBS Group reduced their target price on HCA Healthcare from $289.00 to $241.00 and set a “buy” rating on the stock in a research note on Tuesday, April 26th. TheStreet upgraded HCA Healthcare from a “c+” rating to a “b-” rating in a research note on Monday, March 21st. Wells Fargo & Company reduced their target price on HCA Healthcare from $267.00 to $227.00 and set an “equal weight” rating on the stock in a research note on Monday, April 25th. Oppenheimer set a $255.00 target price on HCA Healthcare in a research note on Monday, June 20th. Finally, Cowen cut their price target on HCA Healthcare from $265.00 to $241.00 in a research note on Monday, April 25th. One research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $241.24.

HCA Healthcare Stock Up 2.5 %

Shares of HCA opened at $171.61 on Monday. The company has a market cap of $50.71 billion, a PE ratio of 8.08, a P/E/G ratio of 1.20 and a beta of 1.65. The business has a fifty day moving average of $191.96 and a 200 day moving average of $228.46. HCA Healthcare has a 52-week low of $164.47 and a 52-week high of $279.02. The company has a quick ratio of 1.24, a current ratio of 1.43 and a debt-to-equity ratio of 87.46.

Hedge Funds Weigh In On HCA Healthcare

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Equitec Proprietary Markets LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $26,000. Baltimore Washington Financial Advisors Inc. acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $26,000. GoalVest Advisory LLC acquired a new position in shares of HCA Healthcare in the 1st quarter valued at $26,000. Amplius Wealth Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at $27,000. Finally, Wolff Wiese Magana LLC lifted its stake in shares of HCA Healthcare by 1,833.3% in the 1st quarter. Wolff Wiese Magana LLC now owns 116 shares of the company’s stock valued at $29,000 after purchasing an additional 110 shares during the last quarter. Institutional investors and hedge funds own 67.87% of the company’s stock.

Insider Activity at HCA Healthcare

In related news, Director Andrea B. Smith purchased 1,160 shares of HCA Healthcare stock in a transaction that occurred on Thursday, April 28th. The stock was bought at an average cost of $213.63 per share, for a total transaction of $247,810.80. Following the completion of the transaction, the director now owns 2,239 shares in the company, valued at $478,317.57. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, major shareholder Thomas F. Frist, Jr. acquired 89,100 shares of the stock in a transaction on Monday, May 2nd. The shares were bought at an average price of $211.93 per share, with a total value of $18,882,963.00. Following the completion of the purchase, the insider now owns 478,955 shares of the company’s stock, valued at approximately $101,504,933.15. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrea B. Smith acquired 1,160 shares of the stock in a transaction on Thursday, April 28th. The shares were bought at an average cost of $213.63 per share, for a total transaction of $247,810.80. Following the purchase, the director now directly owns 2,239 shares of the company’s stock, valued at approximately $478,317.57. The disclosure for this purchase can be found here. Over the last ninety days, insiders purchased 91,370 shares of company stock worth $19,373,375. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, June 30th. Investors of record on Thursday, June 16th were given a dividend of $0.56 per share. This represents a $2.24 annualized dividend and a yield of 1.31%. The ex-dividend date was Wednesday, June 15th. HCA Healthcare’s dividend payout ratio is currently 10.54%.

About HCA Healthcare

(Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Read More

Receive News & Ratings for HCA Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for HCA Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.